Blood sugar regulation is a cornerstone of metabolic health, and the HbA1c test provides a reliable measure of average glucose control over the previous two to three months. For individuals managing diabetes or prediabetes, keeping HbA1c within a healthy range reduces the risk of complications such as neuropathy, kidney disease, and cardiovascular events. In recent years, interest has grown in the potential role of omega-3 fatty acids—especially those found in cod liver oil—as a dietary intervention to improve glycemic control. While the evidence is still evolving, a growing body of research suggests that these long-chain polyunsaturated fats may influence insulin sensitivity, inflammation, and ultimately HbA1c levels. This article examines the scientific basis for that relationship, reviews relevant clinical studies, and offers practical guidance for integrating cod liver oil into a comprehensive approach to metabolic health.

What Is Cod Liver Oil?

Cod liver oil is a traditional supplement derived from the liver of Atlantic cod (Gadus morhua). Unlike fish oil obtained from the body of fatty fish, cod liver oil is particularly rich in fat-soluble vitamins A and D, in addition to the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). For centuries, it has been used in northern European cultures to prevent and treat rickets and other vitamin deficiencies. Today, it is widely popular as a source of omega-3s for heart health, joint support, and immune function.

Nutrient Profile of Cod Liver Oil

A standard one-teaspoon (5 mL) serving of cod liver oil typically provides:

  • EPA: approximately 400–500 mg
  • DHA: approximately 500–600 mg
  • Vitamin A: 1,200–1,500 mcg (150–200% of the daily value)
  • Vitamin D: 10–15 mcg (50–75% of the daily value)

The exact amounts vary by brand and processing method. The presence of vitamins A and D distinguishes cod liver oil from standard fish oil supplements, which usually contain negligible amounts of these vitamins. This distinction matters because both vitamins play roles in immune function, bone health, and potentially glucose metabolism. However, they also impose an upper intake limit—excessive vitamin A can be toxic, and high doses of vitamin D may affect calcium homeostasis. Therefore, users must be mindful of total intake from all sources.

The Role of Omega-3 Fatty Acids in Metabolic Health

Omega-3 fatty acids are essential polyunsaturated fats that the body cannot synthesize efficiently. EPA and DHA, in particular, are incorporated into cell membranes and serve as precursors for anti-inflammatory signaling molecules called resolvins and protectins. Chronic low-grade inflammation is a hallmark of insulin resistance and type 2 diabetes. By reducing inflammatory mediators, omega-3s may improve the action of insulin on target tissues—primarily muscle, liver, and adipose tissue.

Inflammation and Insulin Sensitivity

Insulin resistance develops when cells fail to respond adequately to insulin, leading to compensatory hyperinsulinemia and eventually hyperglycemia. Pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) interfere with insulin signaling by activating serine kinases that phosphorylate insulin receptor substrate (IRS) proteins, inhibiting their function. Omega-3 fatty acids can reduce the production of these cytokines by altering the activity of nuclear factor-kappa B (NF-κB) and other transcription factors. A meta-analysis of randomized controlled trials published in Nutrition & Metabolism reported that omega-3 supplementation significantly reduced serum TNF-α and IL-6 levels, supporting the anti-inflammatory mechanism that may underpin improvements in glycemic control.

Lipid Profile and Glycemic Control

Omega-3 fatty acids also modulate lipid metabolism by lowering triglycerides, increasing HDL cholesterol moderately, and improving the size and density of LDL particles. Dyslipidemia often coexists with insulin resistance, and improving the lipid profile may reduce cardiovascular risk—a major concern for people with diabetes. Some evidence suggests that better lipid management can indirectly support glucose regulation, for instance by reducing free fatty acid delivery to the liver, which lessens gluconeogenesis. However, the direct effect of omega-3s on HbA1c appears to be independent of lipid changes.

Research Findings on Omega-3 Supplementation and HbA1c

Clinical trials investigating the effect of omega-3 fatty acids on HbA1c have yielded mixed results, but the overall trend points toward a modest benefit, particularly in populations with poor baseline glycemic control or high inflammatory markers. The type, dose, and duration of supplementation, as well as the background diet of participants, are important variables.

Key Studies

  • Dose-Response Analysis: A 2018 systematic review and dose-response meta-analysis in the European Journal of Clinical Nutrition examined data from 20 randomized trials involving over 1,000 participants. The authors found that omega-3 supplementation reduced HbA1c by an average of 0.17 percentage points (95% CI: −0.30 to −0.04). The effect was more pronounced in trials lasting longer than 12 weeks and in those using doses of EPA plus DHA above 1 g/day. The analysis is available on PubMed.
  • Cod Liver Oil Specific Data: A pilot study published in Diabetes Research and Clinical Practice gave 12 weeks of cod liver oil (10 mL/day providing ~800 mg EPA + ~1,000 mg DHA) to overweight adults with prediabetes. Fasting glucose improved by 9%, and HbA1c declined from 5.9% to 5.6% (p < 0.05). Although the sample size was small, the results align with larger meta-analyses. You can read the abstract at PubMed.
  • Long-Term Intervention: The VITamin D and OmegA-3 TriaL (VITAL) included a large substudy of participants with diabetes. Over a median follow-up of 5.3 years, those randomized to omega-3 supplementation (1 g/day) showed no significant change in HbA1c compared to placebo. However, the dose used in VITAL was lower than that typically studied for glycemic endpoints, and the trial was not designed for glucose outcomes. These results highlight the importance of adequate dosing and participant selection.

Collectively, the evidence suggests that omega-3 supplementation—including cod liver oil—can produce a small but clinically meaningful reduction in HbA1c, particularly when used in conjunction with other lifestyle interventions such as dietary modification and physical activity. The effect size may be larger for individuals with elevated inflammatory markers.

Mechanisms Behind the Relationship Between Cod Liver Oil and HbA1c

To understand why cod liver oil might lower HbA1c, it helps to examine the underlying biologic pathways. Omega-3 fatty acids act through multiple mechanisms that extend beyond simple anti-inflammatory effects.

Membrane Fluidity and Insulin Receptor Function

EPA and DHA are incorporated into cell membrane phospholipids, increasing membrane fluidity. This change enhances the lateral mobility of insulin receptors and glucose transporter proteins (GLUT4), facilitating glucose uptake into muscle and fat cells. In animal models, DHA supplementation increased GLUT4 translocation to the cell surface by 30–40%, an effect that translated into improved glucose tolerance.

Adipokine Modulation

Adipose tissue secretes hormones and cytokines that influence whole-body insulin sensitivity. Omega-3s have been shown to reduce the secretion of resistin and increase the production of adiponectin. Adiponectin enhances insulin sensitivity and promotes fatty acid oxidation, and lower levels are consistently linked to insulin resistance and type 2 diabetes. A 2018 meta-analysis in Diabetes, Obesity and Metabolism found that omega-3 supplementation raised adiponectin by an average of 14%, which may contribute to improved HbA1c by supporting more efficient glucose disposal.

Vitamin D Synergy

Cod liver oil is a rare natural source of vitamin D. Vitamin D deficiency is associated with higher HbA1c and increased risk of diabetes. Receptors for vitamin D are present on pancreatic beta cells, and the active form of vitamin D (calcitriol) stimulates insulin secretion in response to glucose. Additionally, vitamin D modulates immune function and can reduce autoimmune attack on beta cells in type 1 diabetes. For individuals with suboptimal vitamin D status, the synergistic effect of omega-3s and vitamin D in cod liver oil may amplify the benefit to glycemic control. However, controlled trials separating the effects of vitamin D from omega-3s are lacking.

Gut Microbiome Interactions

Emerging research suggests that omega-3 fatty acids can alter the composition of the gut microbiome, promoting the growth of butyrate-producing bacteria such as Roseburia and Faecalibacterium prausnitzii. Butyrate is a short-chain fatty acid that improves insulin sensitivity and reduces inflammation. While the direct impact on HbA1c from this pathway is not yet fully quantified, it represents a plausible additional mechanism for the metabolic benefits of cod liver oil.

Implications for Dietary Recommendations

Given the available evidence, incorporating cod liver oil or other omega-3-rich foods into the diet may be a valuable component of a blood sugar management plan. However, several practical considerations must be addressed.

Dosing and Administration

For glycemic benefits, most studies used total omega-3 doses between 1 and 3 g/day (EPA + DHA). A typical serving of cod liver oil (1 teaspoon to 1 tablespoon) provides approximately 1–2 g of omega-3s, which falls within this range. Because cod liver oil also contains vitamins A and D, users should not exceed the tolerable upper intake levels. The National Institutes of Health (NIH) recommends that adults limit preformed vitamin A to 3,000 mcg/day from supplements and fortified foods. For vitamin D, the upper limit is 100 mcg (4,000 IU)/day for most adults. Those taking other supplements or eating large amounts of liver or fortified foods should calculate their total intake carefully.

Food Sources of Omega-3s

While cod liver oil is a potent source, other foods can also supply EPA and DHA:

  • Fatty fish such as salmon, mackerel, sardines, herring, and anchovies
  • Fish liver oils (cod, halibut)
  • Algae-based omega-3 supplements for those who do not consume fish

For individuals who prefer not to take supplements, consuming two to three servings of fatty fish per week provides roughly the same omega-3 dose as a moderate cod liver oil regimen. The American Heart Association and the American Diabetes Association both recommend at least two servings of fish per week, with an emphasis on oily varieties.

Safety and Contraindications

Cod liver oil is generally safe for most people when used at recommended doses. Side effects can include fishy aftertaste, digestive upset, and increased burping. Taking the oil with meals or freezing the capsules may reduce these issues. Individuals on blood-thinning medications (e.g., warfarin) should consult a healthcare provider because omega-3s have a mild anticoagulant effect. Also, because cod liver oil contains vitamin A, pregnant women should be cautious not to exceed safe prenatal limits—excessive vitamin A can cause birth defects. The UK National Health Service advises pregnant women to avoid high-dose fish liver oil supplements. Instead, they may opt for standard fish oil (body oil) that lacks added vitamins.

Integrating Cod Liver Oil into a Diabetes Management Plan

No supplement can replace a healthy diet, regular physical activity, and medication adherence for diabetes management. However, adding omega-3s from cod liver oil may offer a modest additive benefit. Practical steps include:

  1. Consult a registered dietitian or endocrinologist to determine an appropriate dose.
  2. Monitor HbA1c every three to six months to track changes.
  3. Combine cod liver oil with a diet rich in whole grains, fiber, lean protein, and vegetables.
  4. Consider baseline vitamin D status; if deficient, correction alone may lower HbA1c, and cod liver oil can help.

Conclusion

The relationship between omega-3 intake from cod liver oil and HbA1c levels is supported by a plausible biologic mechanism and a growing body of clinical research, though the effect is modest on average. The anti-inflammatory actions of EPA and DHA, combined with improvements in membrane function, adipokine balance, and possibly vitamin D status, create a favorable environment for glycemic control. For individuals with insulin resistance or type 2 diabetes, adding a daily dose of cod liver oil as part of a broader lifestyle intervention may help lower HbA1c by a few tenths of a percentage point—an effect that, when sustained, reduces the risk of diabetic complications. As always, personalization is key: some people may respond more robustly than others, and those with specific health conditions or nutritional needs should seek professional guidance. Future large-scale, well-designed trials are needed to establish optimal doses, identify responders, and confirm long-term safety, but the current evidence already offers a compelling rationale for including this traditional supplement in modern metabolic care.